Kowa Pharmaceuticals America, Inc. is a subsidiary of Kowa Company, Ltd., a multinational company headquartered in Nagoya, Japan. With a strong focus on research and development in cardiovascular therapeutics, ophthalmology, and anti-inflammatory agents, Kowa Pharmaceuticals America is committed to the development and commercialization of safe and effective healthcare solutions in the United States.
Driven by a history of compliance and a dedication to providing the best treatment options, Kowa Pharmaceuticals America brings together patients and fosters collaborations to deliver value, working together to elevate the quality of medical care for all.
Generated from the website